Tagger Investors Double Down With $15M in Series B Funding
Jeito Capital, Ridgeback Capital Investments, SV Health Investors and Fidelity Management & Research Company have led a USD 156m Series B funding round for biotechnology business Quell Therapeutics.
Searchlight Capital Partners has invested in Greece-headquartered cruise line company Celestyal Cruises.
Francisco Partners has agreed to sell cybersecurity, data intelligence, and IT operations software specialist Quest Software to Clearlake Capital in a deal believed to value the business at about $5.4bn. The post Francisco Partners seals
Chinese private equity and venture capital major Legend Capital has reportedly hit a $177m first close for its latest US-dollar denominated healthcare fund. The post China’s Legend past halfway for $300m-targeting US-dollar healthcare fund –
Fintech startup Slice has become India's latest unicorn thanks to a hefty $220m investment round backed by Insight Partners, Advent International and Tiger Global. The post India’s Slice hits $1bn valuation through new investment round,
European infra investor Asterion Industrial Partners has invested in fibre cable services provider MS3 to expand the company’s network across the north of England. MS3 said it would enable its existing and future ISP clients to provide
Timeless, a Berlin-based company that lets users buy fractional shares of luxury assets, has picked up a €12m funding round led by EQT Ventures. The post ‘Fractional luxuries’ trader Timeless gets EQT Ventures backing in
Searchlight Capital has invested in Greek Islands and the Eastern Mediterranean-focused cruise operator Celestyal Cruises. The post Searchlight buys into ‘tremendously pandemic-resilient’ cruise industry with Celestyal Cruises deal first appeared on AltAssets Private Equity News.
PAI Partners and Ontario Teachers' Pension Plan (OTPP) have formed a consortium to acquire Veonet, the parent of German ophthalmology group Oberscharrer Gruppe, according to three sources familiar with the situation.
First-round bids were being collected on 26 November for France-based Laboratoires Vivacy, an injectable medical devices specialist, according to three sources familiar with the matter.
Former President Donald J. Trump’s son-in-law is trying to raise capital for his investment firm and is turning to a region that he dealt with extensively while in the White House.
